(Q44743723)

5 December 2017

Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults (English)

1 reference

5 December 2017

1 reference

2

Wendy Keitel

1 reference

5 December 2017

8

Alexander Klimov

1 reference

5 December 2017

3

Robert Belshe

1 reference

5 December 2017

John Treanor

1

1 reference

5 December 2017

James Campbell

4

1 reference

5 December 2017

Gilbert Schiff

5

1 reference

5 December 2017

Ken Zangwill

6

1 reference

5 December 2017

Mark Wolff

7

1 reference

5 December 2017

Roland Levandowski

9

1 reference

5 December 2017

Linda Lambert

10

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

5 December 2017

1 reference

5 December 2017

20

1 reference

5 December 2017

7-8

1 reference

5 December 2017

1099-1105

1 reference

Reactogenicity, immunogenicity, and antibody persistence in adults given inactivated influenza virus vaccines - 1978.

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900440-6

7 January 2021

Serologic responses and systemic reactions in adults after vaccination with monovalent A/USSR/77 and trivalent A/USSR/77, A/Texas/77, B/Hong Kong/72 influenza vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900440-6

7 January 2021

Antigenicity and Reactogenicity of Influenza A/USSR/77 Virus Vaccine in Children -- A Multicentered Evaluation of Dosage and Safety

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900440-6

7 January 2021

Summary of Clinical Trials of Inactivated Influenza Vaccine--1978

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900440-6

7 January 2021

Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900440-6

7 January 2021

Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing-home residents and young volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900440-6

7 January 2021

Influenza vaccines: the effect of vaccine dose on antibody response in primed populations during the ongoing interpandemic period. A review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900440-6

7 January 2021

Efficacy of sequential annual vaccination with inactivated influenza virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900440-6

7 January 2021

Trials of Influenza A/New Jersey/76 Virus Vaccine in Normal Children: An Overview of Age-Related Antigenicity and Reactogenicity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900440-6

7 January 2021

Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900440-6

7 January 2021

10.1016/S0264-410X(01)00440-6

Identifiers

DOI

1 reference

5 December 2017

1 reference